ivermectin - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 mild to moderate

	COVID-19 mild to moderate
ivermectin	Kirti Chaccour Krolewiecki I-TECH ... Shahbaznejad
ivermectin plus doxycycline	NCT04523831 ...

15 studies excluded by filtering options 0

6064	Glorial F, 2020	1	10	0		not a RCT	risk of bias not avaialble
6083	IFORS (Pott-Junior), 2020	2	1	3	excluded		high risk of bias
6369	Ahmed, 2020	1	1	3			high risk of bias
6370	Chachar, 2020	1	1	3			high risk of bias
6381	Espitia-Hernandez, 2020	1	31	0		not a RCT	risk of bias not avaialble
6382	Khan, 2020	0	13	0	selection pending
6383	Soto-Becerra, 2020	0	12	2	selection pending
6384	Spoorthi, 2020	1	31	0		not a RCT	risk of bias not avaialble
6575	Bukhari, 2021	1	1	3			high risk of bias
6624	Babalola, 2021	1	1	3			high risk of bias
6625	Nasir, 2020	2	31	0	excluded	not a RCT	risk of bias not avaialble
6626	RIVET-COV (Mohan) (12mg and 24mg), 2021	1	1	3			high risk of bias
7313	Abd-Elsalam, 2021	1	1	3			high risk of bias
7995	Hazan, 2021	2	32	0	excluded	not a RCT	risk of bias not avaialble
9462	Mayer, 2022	0	0	0	selection pending